Suven Life Sciences Ltd. - Research Center
530239 SUVEN Group (B) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 20 | Mar ' 19 | Mar ' 18 | Mar ' 17 | Mar ' 16 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 12.73 | 12.73 | 12.73 | 12.73 | 12.73 |
| Share application money | - | - | - | - | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 374.95 | 388.99 | 853.97 | 718.80 | 610.74 |
| Loan funds | |||||
| Secured loans | 1.08 | 1.78 | 30.82 | 53.13 | 61.24 |
| Unsecured loans | - | - | 1.98 | 3.29 | 4.56 |
| Total | 388.76 | 403.50 | 899.50 | 787.95 | 689.27 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 43.61 | 39.48 | 375.36 | 348.82 | 443.69 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 18.92 | 17.13 | 67.63 | 43.09 | 138.33 |
| Net block | 24.69 | 22.35 | 307.73 | 305.72 | 305.35 |
| Capital work-in-progress | - | 0.02 | 24.74 | 9.72 | 7.20 |
| Investments | 241.86 | 359.29 | 381.02 | 365.97 | 23.10 |
| Net current assets | |||||
| Current assets, loans & advances | 143.20 | 57.83 | 300.99 | 194.76 | 438.12 |
| Less : current liabilities & provisions | 21.00 | 35.99 | 114.98 | 88.22 | 84.50 |
| Total net current assets | 122.20 | 21.84 | 186.01 | 106.54 | 353.62 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 388.76 | 403.50 | 899.50 | 787.95 | 689.27 |
| Notes: | |||||
| Book value of unquoted investments | 241.86 | 359.29 | 381.02 | 65.08 | 23.05 |
| Market value of quoted investments | - | - | - | 300.89 | 0.05 |
| Contingent liabilities | - | 47.57 | - | 11.77 | 8.04 |
| Number of equity sharesoutstanding (Lacs) | 1272.82 | 1272.82 | 1272.82 | 1272.82 | 1272.82 |
© 2020 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis